Showing results (3391-3400 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 16, 2012
Smoking cessation counseling beliefs and behaviors of outpatient oncology providersKathryn E Weaver, Suzanne C Danhauer, Janet A Tooze, et al.The Oncologist|February 16, 2012
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trialDomenico Sansonno, Gianfranco Lauletta, Sabino Russi, et al.The Oncologist|January 12, 2012
Shared decision making in oncology practice: what do oncologists need to know?Mary C Politi, Jamie L Studts, John W HayslipThe Oncologist|January 12, 2012
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.The Oncologist|January 24, 2012
Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3Paola Nicoletti, Vassiliki M Cartsos, Penelope K Palaska, et al.The Oncologist|January 3, 2012
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysisWillemien van de Water, Esther Bastiaannet, Elysée T M Hille, et al.The Oncologist|January 3, 2012
Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphomaAnna Colpo, Ephraim Hochberg, Yi-Bin ChenThe Oncologist|April 26, 2012
Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapiesDennis L Citrin, Diane L Bloom, James F Grutsch, et al.The Oncologist|February 24, 2012
A new era for the systemic therapy of neuroendocrine tumorsJennifer R Eads, Neal J MeropolPageof 571